For instance, in a study on diagnostic accuracy in Alzheimer’s disease, NfL in CSF was able to differentiate between one of the Alzheimer’s classification subgroups—patients with either tau pathology or neurodegeneration—and healthy controls, although only with an AUC of 0.6921. This evidence concerns the gene MAPT and Alzheimer disease.